Maravai Lifesciences Holdings Inc (MRVI) returns
Maravai Lifesciences returns over 5 years
$1,000 invested in Maravai Lifesciences five years ago was worth $184.68 at the close on October 30, 2026, with dividends reinvested: an average return of -28.7% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +2.0% | — | $1,020 | -0.9% |
| 3 months | +15.7% | — | $1,157 | +2.1% |
| Year to date | +140.3% | — | $2,403 | +11.7% |
| 1 year | +148.7% | — | $2,487 | +12.4% |
| 3 years | +11.6% | +3.7% | $1,116 | +88.5% |
| 5 years | -81.5% | -28.7% | $184.68 | +76.0% |
Maravai Lifesciences return by calendar year
| Year | MRVI | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +140.3% | +11.7% | +128.6% |
| 2025 | -40.4% | +17.7% | -58.1% |
| 2024 | -16.8% | +24.9% | -41.7% |
| 2023 | -54.2% | +26.2% | -80.4% |
| 2022 | -65.8% | -18.2% | -47.7% |
| 2021 | +49.4% | +28.7% | +20.6% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: MRVI financials
No forecast, no recommendation. This page describes Maravai Lifesciences Holdings Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.